← All organizations
Highest phase reached
Phase 1
First clinical trial
Feb 1, 2007First marketed drug
Jan 1, 1971First NDA
Jul 27, 2011Last known activity
Feb 1, 2007
Timeline
1930s
- Jun 14, 1930
timothy grass pollen allergen extract— NDA Secondary Org
1970s
- Jan 1, 1971
Allermed Laboratories— Founded
2010s
- Jul 27, 2011
Coccidioides immitis Spherule - Derived Skin Test Antigen— NDA Organization
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (12)
- orchard grass pollen allergen
- timothy grass pollen allergen extract
- house dust mite allergen
- short ragweed pollen allergen
- cat epidermis allergen
- Coccidioides immitis Spherule - Derived Skin Test Antigen
- redtop grass pollen allergen
- bermuda grass pollen allergen
- kentucky bluegrass pollen allergen
- meadow fescue grass pollen allergen
- sweet vernal grass pollen allergen
- lolium perenne pollen
Recent trials (1)
- NCT00569231CollaboratorPhase 1Feb 1, 2007
Details
- Founded
- San Diego, CA, US Jan 1, 1971
- First NDA
- Jul 27, 2011
- Last known activity
- Feb 1, 2007
Designations held
- Orphan drug